Comparison of mortality prediction scores in elderly patients with ICD for heart failure with reduced ejection fraction.
Heart failure
ICD
Mortality
Prediction scores
Journal
Aging clinical and experimental research
ISSN: 1720-8319
Titre abrégé: Aging Clin Exp Res
Pays: Germany
ID NLM: 101132995
Informations de publication
Date de publication:
Mar 2022
Mar 2022
Historique:
received:
06
07
2021
accepted:
09
08
2021
pubmed:
24
8
2021
medline:
8
3
2022
entrez:
23
8
2021
Statut:
ppublish
Résumé
This investigation aimed to examine and compare the predictive value of MADIT-II, FADES, PACE and SHOCKED scores in predicting one-year and long-term all-cause mortality in implantable cardioverter-defibrillator (ICD) implanted patients, 75 years old and older, since there has been an area of uncertainty about the utility and usefulness of these available risk scores in such cases. In this observational, retrospective study, 189 ICD implanted geriatric patients were divided into two groups according to the presence of long-term mortality in follow-up. The baseline characteristics and laboratory variables were compared between the groups. MADIT-II, FADES, PACE and SHOCKED scores were calculated at the time of ICD implantation. One-year and long-term predictive values of these scores were compared by a receiver-operating curve (ROC) analysis. A ROC analysis showed that the best cutoff value of the MADIT-II score to predict one-year mortality was ≥ 3 with 87% sensitivity and 74% specificity (AUC 0.83; 95% CI 0.73-0.94; p < 0.001) and that for long-term mortality was ≥ 2 with 83% sensitivity and 43% specificity (AUC 0.68; 95% CI 0.60-0.76; p < 0.001). The predictive value of MADIT-II was superior to FADES, PACE and SHOCKED scores in ICD implanted patients who are 75 years and older. MADIT-II score has a significant prognostic value as compared to FADES, PACE and SHOCKED scores for the prediction of one-year and long-term follow-up in geriatric patients with implanted ICDs for heart failure with reduced ejection fraction.
Sections du résumé
BACKGROUND
BACKGROUND
This investigation aimed to examine and compare the predictive value of MADIT-II, FADES, PACE and SHOCKED scores in predicting one-year and long-term all-cause mortality in implantable cardioverter-defibrillator (ICD) implanted patients, 75 years old and older, since there has been an area of uncertainty about the utility and usefulness of these available risk scores in such cases.
METHODS
METHODS
In this observational, retrospective study, 189 ICD implanted geriatric patients were divided into two groups according to the presence of long-term mortality in follow-up. The baseline characteristics and laboratory variables were compared between the groups. MADIT-II, FADES, PACE and SHOCKED scores were calculated at the time of ICD implantation. One-year and long-term predictive values of these scores were compared by a receiver-operating curve (ROC) analysis.
RESULTS
RESULTS
A ROC analysis showed that the best cutoff value of the MADIT-II score to predict one-year mortality was ≥ 3 with 87% sensitivity and 74% specificity (AUC 0.83; 95% CI 0.73-0.94; p < 0.001) and that for long-term mortality was ≥ 2 with 83% sensitivity and 43% specificity (AUC 0.68; 95% CI 0.60-0.76; p < 0.001). The predictive value of MADIT-II was superior to FADES, PACE and SHOCKED scores in ICD implanted patients who are 75 years and older.
CONCLUSION
CONCLUSIONS
MADIT-II score has a significant prognostic value as compared to FADES, PACE and SHOCKED scores for the prediction of one-year and long-term follow-up in geriatric patients with implanted ICDs for heart failure with reduced ejection fraction.
Identifiants
pubmed: 34424489
doi: 10.1007/s40520-021-01960-6
pii: 10.1007/s40520-021-01960-6
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
653-660Informations de copyright
© 2021. The Author(s), under exclusive licence to Springer Nature Switzerland AG.
Références
Bardy GH, Lee KL, Mark DB et al (2005) Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352:225–237
doi: 10.1056/NEJMoa043399
Moss AJ, Hall WJ, Cannom DS, et al (1996) Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators. N Engl J Med 335:1933–1940
doi: 10.1056/NEJM199612263352601
Polewczyk A, Jachec W, Janion M et al (2015) Lead-dependent infective endocarditis: the role of factors predisposing to its development in an analysis of 414 clinical cases. Pacing Clin Electrophysiol 38:846–856
doi: 10.1111/pace.12615
van Rees JB, Borleffs CJ, Bie MK et al (2011) Inappropriate implantable cardioverter–defibrillator shocks: incidence, predictors, and impact on mortality. J Am Coll Cardiol 57:556–562
doi: 10.1016/j.jacc.2010.06.059
Yancy CW, Jessup M, Bozkurt B et al (2017) 2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of cardiology/American heart association task force on clinical practice guidelines and the heart failure society of America. J Am Coll Cardiol 70:776–803
doi: 10.1016/j.jacc.2017.04.025
Zakine C, Garcia R, Narayanan K et al (2019) Prophylactic implantable cardioverter-defibrillator in the very elderly. Europace 21:1063–1069
doi: 10.1093/europace/euz041
Goldenberg I, Vyas AK, Hall WJ et al (2008) Risk stratification for primary implantation of a cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 51:288–296
doi: 10.1016/j.jacc.2007.08.058
Bilchick KC, Stukenborg GJ, Kamath S et al (2012) Prediction of mortality in clinical practice for medicare patients undergoing defibrillator implantation for primary prevention of sudden cardiac death. J Am Coll Cardiol 60:1647–1655
doi: 10.1016/j.jacc.2012.07.028
Kramer DB, Friedman PA, Kallinen LM et al (2012) Development and validation of a risk score to predict early mortality in recipients of implantable cardioverter-defibrillators. Heart Rhythm 9:42–46
doi: 10.1016/j.hrthm.2011.08.031
van Rees JB, Borleffs CJ, Welsenes GH et al (2012) Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score. Heart 98:872–877
doi: 10.1136/heartjnl-2011-300632
Brignole M, Auricchio A, Baron-Esquivias G et al (2013) ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34:2281–2329
Moss AJ, Zareba W, Hall WJ et al (2002) Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883
doi: 10.1056/NEJMoa013474
Saba S, Adelstein E, Wold N et al (2017) Influence of patients’ age at implantation on mortality and defibrillator shocks. Europace 19:802–807
pubmed: 27256416
Sujino Y, Nakano S, Tanno J et al (2019) Clinical implications of the blood urea nitrogen/creatinine ratio in heart failure and their association with haemoconcentration. ESC Heart Fail 6:1274–1282
doi: 10.1002/ehf2.12531
Rizas KD, McNitt S, Hamm W et al (2017) Prediction of sudden and non-sudden cardiac death in post-infarction patients with reduced left ventricular ejection fraction by periodic repolarization dynamics: MADIT-II substudy. Eur Heart J 38:2110–2118
doi: 10.1093/eurheartj/ehx161
Wybauw R (1910) Sur le point d’origine de la systole cardiaque dans l’oreillette droite. Arch internat d Physiol 10:78–90
Garcia R, Boveda S, Defaye P et al (2020) Early mortality after implantable cardioverter defibrillator: Incidence and associated factors. Int J Cardiol 301:114–118
doi: 10.1016/j.ijcard.2019.09.033
Tandri H, Griffith LS, Tang T et al (2006) Clinical course and long-term follow-up of patients receiving implantable cardioverter-defibrillators. Heart Rhythm 3:762–768
doi: 10.1016/j.hrthm.2006.03.027
Naksuk N, Akkaya M, Adabag S (2013) Application of the multicenter automatic defibrillator implantation trial II risk score in a nontrial setting. Am J Cardiol 112:530–532
doi: 10.1016/j.amjcard.2013.04.019
Akoudad S, Dabiri Abkenari L, Schaer BA et al (2017) Comparison of multivariate risk estimation models to predict prognosis in patients with implantable cardioverter defibrillators with or without cardiac resynchronization therapy. Am J Cardiol 119:1414–1420
doi: 10.1016/j.amjcard.2017.01.035
Abete P, Testa G, Della-Morte D et al (2013) Treatment for chronic heart failure in the elderly: current practice and problems. Heart Fail Rev 18:529–551
doi: 10.1007/s10741-012-9363-6